✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Hester Biosciences Ltd.

HESTERBIO

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹1,744 Cr.
P/E
46.39

Hester Biosciences Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
1,744 Cr
PE
PE
46.39
Prom Holding
Prom Holding
53.73 %
ROE (%)
ROE (%)
8.75
ROCE (%)
ROCE (%)
9.12
Div Yield (%)
Div Yield (%)
0.34
Sales
Sales
312 Cr
OPM (%)
OPM (%)
21.16 %
Debt to Equity
Debt to Equity
0.66
View more
Edit Ratio's

About

Hester Biosciences Limited (Hester) is the largest poultry vaccine manufacturer and one of the… Read more
Low
1247
52W Range
High
2780
  • Hester Biosciences
  • Bajaj Healthcare
  • Themis Medicare
  • TJI Pharma - Small Cap

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

New
Edit rows

Forensics

4 Yes

Positive for this company

2 Neutral

Neutral for this company

10 No

Negative for this company

1 No Data

Insufficient data to analyse

Market Share

35 %
(as of Jun 25)
Source/Historic
Poultry Vaccines - Market Share

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Distribution Channel

Operating Profit Break-Up

Capex

Asset Break-Up - Segment

Operational Metrics

    locked
    Select a Metric
    • R&D as a % of Total Sales (%)
      Source

    Peer Comparison

    Corporate Actions

    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less

    FAQs on Hester Biosciences Ltd. Business

    Hester Biosciences Limited, a premier animal healthcare company in India known for poultry vaccines. Established in 1987, it has become a top global manufacturer with Asia's largest animal biological manufacturing unit in Ahmedabad.

    Hester Biosciences major competitors are Bajaj Healthcare, Themis Medicare, NGL Fine-Chem, Kopran, SMS Pharmaceuticals, Shree Ganesh Remed., Morepen Laboratories.
    Market Cap of Hester Biosciences is ₹1,751 Crs.
    While the median market cap of its peers are ₹1,147 Crs.

    Hester Biosciences seems to be less financially stable compared to its competitors.
    Altman Z score of Hester Biosciences is 4.56 and is ranked 6 out of its 8 competitors.

    View FAQ's On Shareprice

    Company Filing

    Discussions & Analysis

    Hester Biosciences Ltd.
    View the discussion on ValuePickr
    Business Analysis - Hester Biosciences - Value Educator
    Pharmaceutical Sector
    How The Pharma Industry Works - PPFAS
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    GLP-1: The Drug Redefining Diabetes, Obesity, and Pharma’s Future - Perpetuity
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC
    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material